{"transactions":[{"id":927862,"issuer":{"id":8386,"kind":"organization","name":"VivoSim Labs, INC."},"owners":[{"id":68503,"kind":"person","name":"Murphy Keith","position":1,"cik":"0001536583","reported_name":"Murphy Keith","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE CHAIRMAN"}}],"security":"Common Stock","published_at":"2026-01-30T00:59:09.000Z","date":"2026-01-27","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are represented by restricted stock units, which shall vest on the earlier of January 27, 2027 or the date of the next annual meeting of stockholders held by the Issuer, subject to acceleration in the event of a change of control."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Effective on March 20, 2025, the Issuer conducted a reverse stock split of its common stock at a ratio of 1-for-12 (the \"Reverse Split\"). All share numbers reported herein give effect to the Reverse Split."}],"balance_after":26053,"source":{"system":"sec-edgar","filing":"0001193125-26-029888","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1497253/000119312526029888/ownership.xml","form_type":"4"}},{"id":1160777,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":68503,"kind":"person","name":"Murphy Keith","position":1,"cik":"0001536583","reported_name":"Murphy Keith","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to Buy)","published_at":"2025-05-02T17:19:45.000Z","date":"2025-04-30","kind":"grant","planned":false,"acquired":true,"shares":11600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made subject to the approval of, and in accordance with the terms of, the Issuer's 2025 Equity Incentive Plan (the \"2025 Plan\"), which will be voted on at the Issuer's 2025 annual meeting of stockholders to be held on June 23, 2025. 100% of the options vest, subject to stockholder approval of the 2025 Plan, on April 30, 2026."}],"balance_after":11600,"derivative":{"exercise_price":0.59,"expiration_date":"2035-04-30","underlying":"Common Stock","underlying_shares":11600},"source":{"system":"sec-edgar","filing":"0001641172-25-008425","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1536583/000164117225008425/ownership.xml","form_type":"4"}},{"id":1438792,"issuer":{"id":8386,"kind":"organization","name":"VivoSim Labs, INC."},"owners":[{"id":68503,"kind":"person","name":"Murphy Keith","position":1,"cik":"0001536583","reported_name":"Murphy Keith","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE CHAIRMAN"}}],"security":"Options (right to buy)","published_at":"2024-08-07T20:01:03.000Z","date":"2024-08-05","kind":"grant","planned":false,"acquired":true,"shares":143731,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option becomes exercisable if, after the grant date, the closing sales price of the Common Stock, as reported on the Nasdaq Capital Market (based on a 90-trading day average), is at least $1.53 (subject to adjustment for stock splits), as confirmed by the Board of Directors or a committee thereof."}],"balance_after":143731,"derivative":{"exercise_price":0.5368,"expiration_date":"2034-08-05","underlying":"Common Stock","underlying_shares":143731},"source":{"system":"sec-edgar","filing":"0000950170-24-092719","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1497253/000095017024092719/ownership.xml","form_type":"4"}},{"id":1438791,"issuer":{"id":8386,"kind":"organization","name":"VivoSim Labs, INC."},"owners":[{"id":68503,"kind":"person","name":"Murphy Keith","position":1,"cik":"0001536583","reported_name":"Murphy Keith","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE CHAIRMAN"}}],"security":"Options (right to buy)","published_at":"2024-08-07T20:01:03.000Z","date":"2024-08-05","kind":"grant","planned":false,"acquired":true,"shares":574923,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in 3 equal annual installments on each of August 5, 2025, August 5, 2026 and August 5, 2027."}],"balance_after":574923,"derivative":{"exercise_price":0.5368,"expiration_date":"2034-08-05","underlying":"Common Stock","underlying_shares":574923},"source":{"system":"sec-edgar","filing":"0000950170-24-092719","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1497253/000095017024092719/ownership.xml","form_type":"4"}},{"id":1438790,"issuer":{"id":8386,"kind":"organization","name":"VivoSim Labs, INC."},"owners":[{"id":68503,"kind":"person","name":"Murphy Keith","position":1,"cik":"0001536583","reported_name":"Murphy Keith","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EXECUTIVE CHAIRMAN"}}],"security":"Common Stock","published_at":"2024-08-07T20:01:03.000Z","date":"2024-08-07","kind":"grant","planned":false,"acquired":true,"shares":19607,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are represented by restricted stock units, which shall vest on the earlier of August 7, 2025 or the date of the annual meeting of stockholders held by the Issuer in 2025, subject to acceleration in the event of a change of control."}],"balance_after":132641,"source":{"system":"sec-edgar","filing":"0000950170-24-092719","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1497253/000095017024092719/ownership.xml","form_type":"4"}},{"id":1736641,"issuer":{"id":8386,"kind":"organization","name":"VivoSim Labs, INC."},"owners":[{"id":68503,"kind":"person","name":"Murphy Keith","position":1,"cik":"0001536583","reported_name":"Murphy Keith","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2023-11-17T23:37:17.000Z","date":"2023-11-17","kind":"grant","planned":false,"acquired":true,"shares":19607,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are represented by restricted stock units, which shall vest on the earlier of November 17, 2024 or the date of the next annual meeting of stockholders held by the Issuer, subject to acceleration in the event of a change of control."}],"balance_after":113034,"source":{"system":"sec-edgar","filing":"0000950170-23-064947","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1497253/000095017023064947/ownership.xml","form_type":"4"}},{"id":2117894,"issuer":{"id":8386,"kind":"organization","name":"VivoSim Labs, INC."},"owners":[{"id":68503,"kind":"person","name":"Murphy Keith","position":1,"cik":"0001536583","reported_name":"Murphy Keith","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2022-11-15T02:10:11.000Z","date":"2022-11-10","kind":"grant","acquired":true,"shares":19607,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are represented by restricted stock units, which shall vest on the earlier of November 9, 2023 or the date of the next annual meeting of stockholders held by the Issuer, subject to acceleration in the event of a change of control."}],"balance_after":93427,"source":{"system":"sec-edgar","filing":"0000899243-22-035796","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1497253/000089924322035796/doc4.xml","form_type":"4"}},{"id":2134134,"issuer":{"id":8386,"kind":"organization","name":"VivoSim Labs, INC."},"owners":[{"id":68503,"kind":"person","name":"Murphy Keith","position":1,"cik":"0001536583","reported_name":"Murphy Keith","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-10-20T10:05:19.000Z","date":"2022-08-31","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares will vest on a quarterly basis over a period of forty-eight (48) months from August 31, 2022."}],"balance_after":40000,"derivative":{"exercise_price":2.36,"expiration_date":"2032-08-31","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0000899243-22-033855","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1497253/000089924322033855/doc4.xml","form_type":"4"}},{"id":2544480,"issuer":{"id":8386,"kind":"organization","name":"VivoSim Labs, INC."},"owners":[{"id":68503,"kind":"person","name":"Murphy Keith","position":1,"cik":"0001536583","reported_name":"Murphy Keith","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-12T22:00:47.000Z","date":"2021-10-07","kind":"grant","acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option shares shall vest and become exercisable on the earlier of the first anniversary of the grant date or the date of the next annual meeting of stockholders."}],"balance_after":17500,"derivative":{"exercise_price":6.7,"expiration_date":"2031-10-07","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0000899243-21-039910","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1497253/000089924321039910/doc4.xml","form_type":"4"}},{"id":2544479,"issuer":{"id":8386,"kind":"organization","name":"VivoSim Labs, INC."},"owners":[{"id":68503,"kind":"person","name":"Murphy Keith","position":1,"cik":"0001536583","reported_name":"Murphy Keith","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-12T22:00:47.000Z","date":"2021-10-07","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option becomes exercisable, if at all, if the 45-day moving average closing price of the Issuer's common stock on The Nasdaq Stock Market LLC exceeds $35.00 per share."}],"balance_after":60000,"derivative":{"exercise_price":6.7,"expiration_date":"2031-10-07","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0000899243-21-039910","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1497253/000089924321039910/doc4.xml","form_type":"4"}},{"id":2544478,"issuer":{"id":8386,"kind":"organization","name":"VivoSim Labs, INC."},"owners":[{"id":68503,"kind":"person","name":"Murphy Keith","position":1,"cik":"0001536583","reported_name":"Murphy Keith","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-12T22:00:47.000Z","date":"2021-10-07","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option becomes exercisable, if at all, if the 45-day moving average closing price of the Issuer's common stock on The Nasdaq Stock Market LLC exceeds $30.00 per share."}],"balance_after":60000,"derivative":{"exercise_price":6.7,"expiration_date":"2031-10-07","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0000899243-21-039910","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1497253/000089924321039910/doc4.xml","form_type":"4"}},{"id":2561970,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":68503,"kind":"person","name":"Murphy Keith","position":1,"cik":"0001536583","reported_name":"Murphy Keith","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (Right to Buy)","published_at":"2021-09-23T00:43:25.000Z","date":"2021-09-22","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made to reporting person pursuant to the 2017 Omnibus Equity Incentive Plan, as amended. Subject to continued service, the options vest in 12 equal monthly installments commencing on October 22, 2021."}],"balance_after":100000,"derivative":{"exercise_price":1.24,"expiration_date":"2031-09-22","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000905718-21-001227","document":"kintara_fm4sep222021.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000090571821001227/kintara_fm4sep222021.xml","form_type":"4"}},{"id":2796957,"issuer":{"id":8386,"kind":"organization","name":"VivoSim Labs, INC."},"owners":[{"id":68503,"kind":"person","name":"Murphy Keith","position":1,"cik":"0001536583","reported_name":"Murphy Keith","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-10T21:46:31.000Z","date":"2021-03-08","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option becomes exercisable, if at all, if the 45-day moving average closing price of Organovo Holdings, Inc.'s common stock on The Nasdaq Stock Market LLC exceeds $25.00 per share."}],"balance_after":60000,"derivative":{"exercise_price":10.27,"expiration_date":"2031-03-08","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0000899243-21-010982","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1497253/000089924321010982/doc4.xml","form_type":"4"}},{"id":2796956,"issuer":{"id":8386,"kind":"organization","name":"VivoSim Labs, INC."},"owners":[{"id":68503,"kind":"person","name":"Murphy Keith","position":1,"cik":"0001536583","reported_name":"Murphy Keith","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-10T21:46:31.000Z","date":"2021-03-08","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option becomes exercisable, if at all, if the 45-day moving average closing price of Organovo Holdings, Inc.'s common stock on The Nasdaq Stock Market LLC exceeds $20.00 per share."}],"balance_after":60000,"derivative":{"exercise_price":10.27,"expiration_date":"2031-03-08","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0000899243-21-010982","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1497253/000089924321010982/doc4.xml","form_type":"4"}},{"id":2796955,"issuer":{"id":8386,"kind":"organization","name":"VivoSim Labs, INC."},"owners":[{"id":68503,"kind":"person","name":"Murphy Keith","position":1,"cik":"0001536583","reported_name":"Murphy Keith","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-10T21:46:31.000Z","date":"2021-03-08","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the option shares vest and become exercisable on March 8, 2022 and the remaining shares vest in 12 equal quarterly installments thereafter."}],"balance_after":45000,"derivative":{"exercise_price":10.27,"expiration_date":"2031-03-08","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0000899243-21-010982","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1497253/000089924321010982/doc4.xml","form_type":"4"}},{"id":2796954,"issuer":{"id":8386,"kind":"organization","name":"VivoSim Labs, INC."},"owners":[{"id":68503,"kind":"person","name":"Murphy Keith","position":1,"cik":"0001536583","reported_name":"Murphy Keith","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2021-03-10T21:46:31.000Z","date":"2021-03-08","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are represented by restricted stock units, 25% of which shall vest on March 8, 2022 and the remaining shares vest in 12 equal quarterly installments thereafter."}],"balance_after":66320,"source":{"system":"sec-edgar","filing":"0000899243-21-010982","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1497253/000089924321010982/doc4.xml","form_type":"4"}},{"id":2948650,"issuer":{"id":8386,"kind":"organization","name":"VivoSim Labs, INC."},"owners":[{"id":68503,"kind":"person","name":"Murphy Keith","position":1,"cik":"0001536583","reported_name":"Murphy Keith","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-12T00:37:04.000Z","date":"2020-09-15","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"As previously reported on a Form 4 filed on September 17, 2020 by the Reporting Person, the Reporting Person reported acquiring stock options to purchase 130,000 shares of common stock. However, Organovo Holdings, Inc. (the \"Company\") subsequently determined that stock options to purchase 65,000 shares of common stock under the Company's 2012 Equity Incentive Plan, as amended (the \"Plan\"), were not validly granted pursuant to the Plan because they exceeded the Plan limit on the number of stock options that may be granted to any one person during any calendar year. Accordingly, the attempted grant of these excess stock options was ineffective, and they were never granted to the Reporting Person. The Reporting Person is filing this amendment to report the correct amount of stock options acquired."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the option shares vest and become exercisable on September 15, 2021 and the remaining shares vest in 12 equal quarterly installments thereafter."}],"balance_after":65000,"derivative":{"exercise_price":7.64,"expiration_date":"2030-09-15","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0000899243-20-033636","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1497253/000089924320033636/doc4a.xml","form_type":"4/A","original_submission_date":"2020-09-17"}},{"id":3028420,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":68503,"kind":"person","name":"Murphy Keith","position":1,"cik":"0001536583","reported_name":"Murphy Keith","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (Right to Buy)","published_at":"2020-09-18T01:00:48.000Z","date":"2020-09-15","kind":"grant","acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made to reporting person pursuant to the 2017 Omnibus Equity Incentive Plan, as amended. Subject to continued service, the options vest in 12 equal monthly installments commencing on October 15, 2020."}],"balance_after":120000,"derivative":{"exercise_price":1.7,"expiration_date":"2030-09-15","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0000905718-20-000963","document":"kintara_fm4sep152020.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000090571820000963/kintara_fm4sep152020.xml","form_type":"4"}},{"id":3028415,"issuer":{"id":8386,"kind":"organization","name":"VivoSim Labs, INC."},"owners":[{"id":68503,"kind":"person","name":"Murphy Keith","position":1,"cik":"0001536583","reported_name":"Murphy Keith","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-09-17T23:25:36.000Z","date":"2020-09-15","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shares vest and become exercisable over 12 equal quarterly installments measured from September 15, 2020."}],"balance_after":35000,"derivative":{"exercise_price":7.64,"expiration_date":"2030-09-15","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001209191-20-051052","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1497253/000120919120051052/doc4.xml","form_type":"4"}},{"id":3028414,"issuer":{"id":8386,"kind":"organization","name":"VivoSim Labs, INC."},"owners":[{"id":68503,"kind":"person","name":"Murphy Keith","position":1,"cik":"0001536583","reported_name":"Murphy Keith","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-09-17T23:25:36.000Z","date":"2020-09-15","kind":"grant","acquired":true,"shares":130000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the option shares vest and become exercisable on September 15, 2021 and the remaining shares vest in 12 equal quarterly installments thereafter."}],"balance_after":130000,"derivative":{"exercise_price":7.64,"expiration_date":"2030-09-15","underlying":"Common Stock","underlying_shares":130000},"source":{"system":"sec-edgar","filing":"0001209191-20-051052","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1497253/000120919120051052/doc4.xml","form_type":"4"}},{"id":3049890,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":68503,"kind":"person","name":"Murphy Keith","position":1,"cik":"0001536583","reported_name":"Murphy Keith","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-21T20:16:34.000Z","date":"2020-08-19","kind":"purchase","acquired":true,"shares":181010,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Received in exchange for 115,000 shares of Adgero Biopharmaceuticals Holdings, Inc. (\"Adgero\") common stock, par value $0.0001 per share, in connection with the completion of the merger (the \"Merger\"), on August 19, 2020 (the \"Effective Date\"), of Adgero Acquisition Corp., a subsidiary of the Issuer, with and into Adgero, pursuant to the Agreement and Plan of Merger and Reorganization, dated as of June 9, 2020. On the Effective Date, each share of Adgero common stock was converted automatically into the right to receive 1.5740 shares of the Issuer's common stock, par value $0.001 per share."}],"balance_after":181010,"source":{"system":"sec-edgar","filing":"0001213900-20-023271","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000121390020023271/ownership.xml","form_type":"4"}},{"id":4144367,"issuer":{"id":8386,"kind":"organization","name":"VivoSim Labs, INC."},"owners":[{"id":68503,"kind":"person","name":"Murphy Keith","position":1,"cik":"0001536583","reported_name":"Murphy Keith","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former affiliate last filing"}}],"security":"Common Stock","published_at":"2017-12-04T14:00:09.000Z","date":"2017-11-24","kind":"purchase","acquired":true,"shares":200500,"price":1.493,"value":299346.5,"ownership":{"direct":true},"balance_after":6373673,"source":{"system":"sec-edgar","filing":"0001536583-17-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1497253/000153658317000002/primary_doc.xml","form_type":"4"}},{"id":4144366,"issuer":{"id":8386,"kind":"organization","name":"VivoSim Labs, INC."},"owners":[{"id":68503,"kind":"person","name":"Murphy Keith","position":1,"cik":"0001536583","reported_name":"Murphy Keith","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former affiliate last filing"}}],"security":"Common Stock","published_at":"2017-12-04T14:00:09.000Z","date":"2017-11-22","kind":"purchase","acquired":true,"shares":135000,"price":1.496,"value":201960.0,"ownership":{"direct":true},"balance_after":6173173,"source":{"system":"sec-edgar","filing":"0001536583-17-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1497253/000153658317000002/primary_doc.xml","form_type":"4"}},{"id":4328279,"issuer":{"id":8386,"kind":"organization","name":"VivoSim Labs, INC."},"owners":[{"id":68503,"kind":"person","name":"Murphy Keith","position":1,"cik":"0001536583","reported_name":"Murphy Keith","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-09T22:03:08.000Z","date":"2017-02-14","kind":"gift","acquired":false,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction represents charitable contributions by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number does not include 1,831,454 shares of common stock underlying outstanding options held by Mr. Murphy; post-transaction Mr. Murphy continues to beneficially own or have a right to acquire 7,850,627 shares of common stock."}],"balance_after":6019173,"source":{"system":"sec-edgar","filing":"0001209191-17-031051","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1497253/000120919117031051/doc5.xml","form_type":"5"}},{"id":4436095,"issuer":{"id":8386,"kind":"organization","name":"VivoSim Labs, INC."},"owners":[{"id":68503,"kind":"person","name":"Murphy Keith","position":1,"cik":"0001536583","reported_name":"Murphy Keith","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, CEO and President"}}],"security":"Common Stock","published_at":"2017-02-21T23:01:39.000Z","date":"2017-02-16","kind":"tax_withholding","acquired":false,"shares":5742,"price":2.95,"value":16938.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the mandatory sale of shares to satisfy the Reporting Person's tax withholding obligations, in connection with the partial vesting and settlement of restricted stock units granted in July 2016, pursuant to the Reporting Person's agreement with the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number does not include 1,831,454 shares of common stock underlying outstanding options held by Mr. Murphy; post-transaction Mr. Murphy continues to beneficially own or have a right to acquire 7,869,627 shares of common stock."}],"balance_after":6038173,"source":{"system":"sec-edgar","filing":"0001209191-17-012853","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1497253/000120919117012853/doc4.xml","form_type":"4"}},{"id":4457210,"issuer":{"id":8386,"kind":"organization","name":"VivoSim Labs, INC."},"owners":[{"id":68503,"kind":"person","name":"Murphy Keith","position":1,"cik":"0001536583","reported_name":"Murphy Keith","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, CEO and President"}}],"security":"Warrant","published_at":"2017-02-10T23:39:25.000Z","date":"2017-02-08","kind":"exercise","acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The Reporting Person exercised warrants to purchase 30,000 shares of the Issuer's common stock for $1.00 a share. The warrant would have expired by its terms if not exercised by the Reporting Person on February 8, 2017."}],"balance_after":0,"derivative":{"exercise_price":1,"exercise_date":"2012-02-08","expiration_date":"2017-02-08","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-17-009742","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1497253/000120919117009742/doc4.xml","form_type":"4"}},{"id":4457209,"issuer":{"id":8386,"kind":"organization","name":"VivoSim Labs, INC."},"owners":[{"id":68503,"kind":"person","name":"Murphy Keith","position":1,"cik":"0001536583","reported_name":"Murphy Keith","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, CEO and President"}}],"security":"Common Stock","published_at":"2017-02-10T23:39:25.000Z","date":"2017-02-09","kind":"sale","acquired":false,"shares":25000,"price":3.6814,"value":92035.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $3.63 to $3.74.  The price reported in this column reflects the weighted average sale price.  The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"This number does not include 1,831,454 shares of common stock underlying outstanding options held by Mr. Murphy; post-transaction Mr. Murphy continues to beneficially own or have a right to acquire 7,875,369 shares of common stock."}],"balance_after":6043915,"source":{"system":"sec-edgar","filing":"0001209191-17-009742","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1497253/000120919117009742/doc4.xml","form_type":"4"}},{"id":4457208,"issuer":{"id":8386,"kind":"organization","name":"VivoSim Labs, INC."},"owners":[{"id":68503,"kind":"person","name":"Murphy Keith","position":1,"cik":"0001536583","reported_name":"Murphy Keith","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, CEO and President"}}],"security":"Common Stock","published_at":"2017-02-10T23:39:25.000Z","date":"2017-02-08","kind":"exercise","acquired":true,"shares":30000,"price":1,"value":30000.0,"ownership":{"direct":false,"nature":"IRA"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The Warrants are held by the Equity Trust Co. Custodian FBO Keith Murphy IRA."}],"balance_after":6068915,"source":{"system":"sec-edgar","filing":"0001209191-17-009742","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1497253/000120919117009742/doc4.xml","form_type":"4"}},{"id":4481900,"issuer":{"id":8386,"kind":"organization","name":"VivoSim Labs, INC."},"owners":[{"id":68503,"kind":"person","name":"Murphy Keith","position":1,"cik":"0001536583","reported_name":"Murphy Keith","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, CEO and President"}}],"security":"Common Stock","published_at":"2017-01-25T21:27:31.000Z","date":"2017-01-24","kind":"sale","acquired":false,"shares":20100,"price":3.5045,"value":70440.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of shares was effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $3.50 to $3.515. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"This number does not include 1,831,454 shares of common stock underlying oustanding options and 30,000 shares of common stock underlying warrants held by Mr. Murphy; post-transaction Mr. Murphy continues to beneficially own or have a right to acquire 7,900,369 shares of common stock."}],"balance_after":6038915,"source":{"system":"sec-edgar","filing":"0001209191-17-005511","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1497253/000120919117005511/doc4.xml","form_type":"4"}},{"id":4481899,"issuer":{"id":8386,"kind":"organization","name":"VivoSim Labs, INC."},"owners":[{"id":68503,"kind":"person","name":"Murphy Keith","position":1,"cik":"0001536583","reported_name":"Murphy Keith","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, CEO and President"}}],"security":"Common Stock","published_at":"2017-01-25T21:27:31.000Z","date":"2017-01-23","kind":"sale","acquired":false,"shares":4900,"price":3.5133,"value":17215.17,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of shares was effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $3.50 to $3.54. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":6059015,"source":{"system":"sec-edgar","filing":"0001209191-17-005511","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1497253/000120919117005511/doc4.xml","form_type":"4"}},{"id":4520579,"issuer":{"id":8386,"kind":"organization","name":"VivoSim Labs, INC."},"owners":[{"id":68503,"kind":"person","name":"Murphy Keith","position":1,"cik":"0001536583","reported_name":"Murphy Keith","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, CEO and President"}}],"security":"Common Stock","published_at":"2016-12-15T22:35:34.000Z","date":"2016-12-14","kind":"sale","acquired":false,"shares":50000,"price":3.7191,"value":185955.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of shares was effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $3.65 to $3.80. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This number does not include 1,831,454 shares of common stock underlying oustanding options and 30,000 shares of common stock underlying warrants held by Mr. Murphy; post-transaction Mr. Murphy continues to beneficially own or have a right to acquire 7,925,369 shares of common stock."}],"balance_after":6063915,"source":{"system":"sec-edgar","filing":"0001209191-16-155477","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1497253/000120919116155477/doc4.xml","form_type":"4"}},{"id":4548735,"issuer":{"id":8386,"kind":"organization","name":"VivoSim Labs, INC."},"owners":[{"id":68503,"kind":"person","name":"Murphy Keith","position":1,"cik":"0001536583","reported_name":"Murphy Keith","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, CEO and President"}}],"security":"Common Stock","published_at":"2016-11-18T22:08:36.000Z","date":"2016-11-16","kind":"tax_withholding","acquired":false,"shares":7200,"price":3.2594,"value":23467.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the mandatory sale of shares to satisfy the Reporting Person's tax withholding obligations, in connection with the partial vesting and settlement of restricted stock units granted in July 2016, pursuant to the Reporting Person's agreement with the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number does not include 1,831,454 shares of common stock underlying oustanding options and 30,000 shares of common stock underlying warrants held by Mr. Murphy; post-transaction Mr. Murphy continues to beneficially own or have a right to acquire 7,975,369 shares of common stock."}],"balance_after":6113915,"source":{"system":"sec-edgar","filing":"0001209191-16-151275","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1497253/000120919116151275/doc4.xml","form_type":"4"}},{"id":4599038,"issuer":{"id":8386,"kind":"organization","name":"VivoSim Labs, INC."},"owners":[{"id":68503,"kind":"person","name":"Murphy Keith","position":1,"cik":"0001536583","reported_name":"Murphy Keith","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, CEO and President"}}],"security":"Common Stock","published_at":"2016-09-20T21:02:56.000Z","date":"2016-09-16","kind":"tax_withholding","acquired":false,"shares":1394,"price":4,"value":5576.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transaction represents the mandatory withholding of shares by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the partial vesting and settlement of restricted stock units granted in July 2016."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number does not include 1,831,454 shares of common stock underlying oustanding options and 30,000 shares of common stock underlying warrants held by Mr. Murphy; post-transaction Mr. Murphy continues to beneficially own or have a right to acquire 7,982,569 shares of common stock."}],"balance_after":6121115,"source":{"system":"sec-edgar","filing":"0001209191-16-142170","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1497253/000120919116142170/doc4.xml","form_type":"4"}}]}